BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 18282769)

  • 1. Methylphenidate DAT binding in adolescents with Attention-Deficit/ Hyperactivity Disorder comorbid with Substance Use Disorder--a single photon emission computed tomography with [Tc(99m)]TRODAT-1 study.
    Szobot CM; Shih MC; Schaefer T; Júnior N; Hoexter MQ; Fu YK; Pechansky F; Bressan RA; Rohde LA
    Neuroimage; 2008 Apr; 40(3):1195-201. PubMed ID: 18282769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic imaging study with [Tc-
    Akay AP; Kaya GÇ; Kose S; Yazıcıoğlu ÇE; Erkuran HÖ; Güney SA; Oğuz K; Keskin D; Baykara B; Emiroğlu Nİ; Eren MŞ; Kızıldağ S; Ertay T; Özsoylu D; Miral S; Durak H; Gönül AS; Rohde LA
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Aug; 86():294-300. PubMed ID: 29684537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Searching for a neurobiological basis for self-medication theory in ADHD comorbid with substance use disorders: an in vivo study of dopamine transporters using (99m)Tc-TRODAT-1 SPECT.
    Silva N; Szobot CM; Shih MC; Hoexter MQ; Anselmi CE; Pechansky F; Bressan RA; Rohde LA
    Clin Nucl Med; 2014 Feb; 39(2):e129-34. PubMed ID: 23856832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular imaging genetics of methylphenidate response in ADHD and substance use comorbidity.
    Szobot CM; Roman T; Hutz MH; Genro JP; Shih MC; Hoexter MQ; Júnior N; Pechansky F; Bressan RA; Rohde LA
    Synapse; 2011 Feb; 65(2):154-9. PubMed ID: 20593420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low dopamine transporter occupancy by methylphenidate as a possible reason for reduced treatment effectiveness in ADHD patients with cocaine dependence.
    Crunelle CL; van den Brink W; Veltman DJ; van Emmerik-van Oortmerssen K; Dom G; Schoevers RA; Booij J
    Eur Neuropsychopharmacol; 2013 Dec; 23(12):1714-23. PubMed ID: 23731497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of 99mTc-TRODAT-1 SPECT to predict clinical response to methylphenidate treatment in adults with attention deficit hyperactivity disorder.
    la Fougère C; Krause J; Krause KH; Josef Gildehaus F; Hacker M; Koch W; Hahn K; Tatsch K; Dresel S
    Nucl Med Commun; 2006 Sep; 27(9):733-7. PubMed ID: 16894328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of striatal dopamine transporter availability on the response to methylphenidate in adult patients with ADHD.
    Krause J; la Fougere C; Krause KH; Ackenheil M; Dresel SH
    Eur Arch Psychiatry Clin Neurosci; 2005 Dec; 255(6):428-31. PubMed ID: 16091862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized crossover clinical study showing that methylphenidate-SODAS improves attention-deficit/hyperactivity disorder symptoms in adolescents with substance use disorder.
    Szobot CM; Rohde LA; Katz B; Ruaro P; Schaefer T; Walcher M; Bukstein O; Pechansky F
    Braz J Med Biol Res; 2008 Mar; 41(3):250-7. PubMed ID: 18327433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attention deficit hyperactivity disorder: binding of [99mTc]TRODAT-1 to the dopamine transporter before and after methylphenidate treatment.
    Dresel S; Krause J; Krause KH; LaFougere C; Brinkbäumer K; Kung HF; Hahn K; Tatsch K
    Eur J Nucl Med; 2000 Oct; 27(10):1518-24. PubMed ID: 11083541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attention deficit/hyperactivity disorder: is there a correlation between dopamine transporter density and cerebral blood flow?
    da Silva N; Szobot CM; Anselmi CE; Jackowski AP; Chi SM; Hoexter MQ; Anselmi OE; Pechansky F; Bressan RA; Rohde LA
    Clin Nucl Med; 2011 Aug; 36(8):656-60. PubMed ID: 21716015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: effects of methylphenidate as measured by single photon emission computed tomography.
    Krause KH; Dresel SH; Krause J; Kung HF; Tatsch K
    Neurosci Lett; 2000 May; 285(2):107-10. PubMed ID: 10793238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The rCBF brain mapping in adolescent ADHD comorbid developmental coordination disorder and its changes after MPH challenging.
    Yeh CB; Huang WS; Lo MC; Chang CJ; Ma KH; Shyu JF
    Eur J Paediatr Neurol; 2012 Nov; 16(6):613-8. PubMed ID: 22417719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The homozygosity for 10-repeat allele at dopamine transporter gene and dopamine transporter density in Korean children with attention deficit hyperactivity disorder: relating to treatment response to methylphenidate.
    Cheon KA; Ryu YH; Kim JW; Cho DY
    Eur Neuropsychopharmacol; 2005 Jan; 15(1):95-101. PubMed ID: 15572278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phasic dysfunction of dopamine transmission in Tourette's syndrome evaluated with 99mTc TRODAT-1 imaging.
    Yeh CB; Lee CS; Ma KH; Lee MS; Chang CJ; Huang WS
    Psychiatry Res; 2007 Oct; 156(1):75-82. PubMed ID: 17716877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-deficit/hyperactivity disorder.
    Volkow ND; Wang GJ; Newcorn J; Telang F; Solanto MV; Fowler JS; Logan J; Ma Y; Schulz K; Pradhan K; Wong C; Swanson JM
    Arch Gen Psychiatry; 2007 Aug; 64(8):932-40. PubMed ID: 17679638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine transporter density in the basal ganglia assessed with [123I]IPT SPET in children with attention deficit hyperactivity disorder.
    Cheon KA; Ryu YH; Kim YK; Namkoong K; Kim CH; Lee JD
    Eur J Nucl Med Mol Imaging; 2003 Feb; 30(2):306-11. PubMed ID: 12552351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SPECT and PET of the dopamine transporter in attention-deficit/hyperactivity disorder.
    Krause J
    Expert Rev Neurother; 2008 Apr; 8(4):611-25. PubMed ID: 18416663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity.
    Jucaite A; Fernell E; Halldin C; Forssberg H; Farde L
    Biol Psychiatry; 2005 Feb; 57(3):229-38. PubMed ID: 15691523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Availability of Striatal Dopamine Transporter in Healthy Individuals With and Without a Family History of ADHD.
    Tai YC; Chi MH; Chu CL; Chiu NT; Yao WJ; Chen PS; Yang YK
    J Atten Disord; 2019 May; 23(7):665-670. PubMed ID: 27401239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Availability of dopamine transporters and auditory P300 abnormalities in adults with attention-deficit hyperactivity disorder: preliminary results.
    Chu CL; Lee IH; Chi MH; Chen KC; Chen PS; Yao WJ; Chiu NT; Yang YK
    CNS Spectr; 2018 Aug; 23(4):264-270. PubMed ID: 28847342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.